Limbic AI

Limbic AI provides clinical artificial intelligence tools designed to augment mental healthcare services for providers like the UK's National Health Service (NHS) and U.S. health systems. The company was founded in 2017 by Dr. Ross Harper (CEO), a computational neuroscientist, and Sebastiaan de Vries (CTO), an experienced tech founder, to address the significant gap between the demand for mental health services and the availability of clinical professionals. Dr. Harper holds a PhD in Computational Neuroscience from University College London and a Master's from the University of Cambridge, bringing a deep understanding of the intersection of technology and the human mind to the company's mission.

Limbic's core technology is the 'Limbic Layer,' a proprietary AI engine that sits between a large language model (LLM) and the user to ensure interactions are safe, clinically valid, and compliant with medical device regulations. This technology has enabled Limbic to become the first mental health AI chatbot to achieve Class IIa UKCA medical device certification, signifying its adherence to high standards for clinical effectiveness and safety. The platform offers a suite of products, including Limbic Access, an AI-powered chatbot that automates patient intake, triage, and clinical assessment, and Limbic Care, a generative AI companion app that provides on-demand cognitive behavioral therapy (CBT) exercises and support for patients between appointments. The business model is B2B, selling its software to healthcare organizations to help them scale access, improve efficiency, and enhance patient outcomes. By integrating with existing patient management systems, the platform reduces administrative workloads for clinicians, allowing them to focus on direct patient care.

Since its launch, Limbic has been adopted by over 40% of NHS Talking Therapies services, supporting hundreds of thousands of patients and saving significant clinical hours. The company has demonstrated a measurable impact, including increasing self-referrals among minority groups, reducing patient dropout rates, and improving recovery rates. After establishing a strong presence in the UK, Limbic raised $14 million in a Series A round led by Khosla Ventures in March 2024 to fuel its expansion into the U.S. market, where it is now active in numerous states.

Keywords: clinical AI, mental healthcare, behavioral health, AI chatbot, patient triage, clinical decision support, generative AI, digital therapeutics, cognitive behavioral therapy, health-tech, patient intake automation, computational psychiatry, NHS, mental health assessment, care pathway automation, clinical workflow, digital mental health, patient engagement, risk stratification, healthcare AI